Gudrun Schleiermacher

Control-FREEC: a tool for assessing copy number and allelic content using next-generation sequencing data

Valentina Boeva, Tatiana Popova, Kevin Bleakley et al. · Bioinformatics · 2011 · 1.1K citations · Full text

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

Isabelle Janoueix‐Lerosey, Delphine Lequin, Laurence Brugières et al. · Nature · 2008 · 887 citations

Somatic Variant, Receptor Tyrosine Kinase, Alk Kinase Receptor +5

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

Thomas F. Eleveld, Derek A. Oldridge, Virginie Bernard et al. · Nature Genetics · 2015 · 543 citations

Receptor Tyrosine Kinase, Pathology, Neuroblasts +5

Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries

Valentina Boeva, Caroline Louis‐Brennetot, Agathe Peltier et al. · Nature Genetics · 2017 · 492 citations · Full text

Neuro-oncology, Lineage Plasticity, Developmental Biology +6

International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee

Peter F. Ambros, I.M. Ambros, G M Brodeur et al. · British Journal of Cancer · 2009 · 397 citations · Full text

Prognostic Biomarkers, Neuroblastoma Treatment Planning, Medicine +14